Advanced search
Publication Cover
Future Oncology Volume 6, 2010 - Issue 9
Submit an article Journal homepage
886
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Metabolomics and Detection of Colorectal Cancer in Humans: A Systematic Review

Haili Wang1 University of Alberta, Room #L-10B Zeidler Ledcor Centre, 130 University Campus, 112th St & 85th Avenue, Edmonton, AB T6G 2X8, Canada. [email protected]Correspondence[email protected]
View further author information
,
Victor K Tso1 University of Alberta, Room #L-10B Zeidler Ledcor Centre, 130 University Campus, 112th St & 85th Avenue, Edmonton, AB T6G 2X8, Canada. [email protected]View further author information
,
Carolyn M Slupsky2 University of California Davis, CA, USAView further author information
&
Richard N Fedorak1 University of Alberta, Room #L-10B Zeidler Ledcor Centre, 130 University Campus, 112th St & 85th Avenue, Edmonton, AB T6G 2X8, Canada. [email protected]View further author information
Pages 1395-1406 | Published online: 04 Oct 2010

Bibliography

  • Leddin D , HuntR, ChampionMet al.: Canadian Association of Gatroenterology and the Canadian Digestive Health Foundation: guidelines on colon cancer screening.Can. J. Gastroenterol.18(2), 93–99 (2004).
  • Rex DK , JohnsonDA, AndersonJC, SchoenfeldPS, BurkeCA, InadomiJM: American College of Gastroenterology guidelines for colorectal cancer screening 2008.Am. J. Gastroenterol.104(3), 739–750 (2009).
  • Ramsoekh D , van LeerdamME, van BallegooijenM, HabbemaJDF, KuipersEJ: Population screening for colorectal cancer: faeces, endoscopes or x-rays?Cell. Oncol.23(3), 185–194 (2007).
  • O’Leary BA , OlynykJK, NevilleAM, PlatellCF: Cost-effectiveness of colorectal cancer screening: Comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.J. Gastroenterol. Hepatol.19(1), 38–47 (2004).
  • Wang H , SlupskyC, SawyerM, WongC, SchillerD, FedorakR: The role of NMR urine metabolomics as a new method for screening colorectal cancer – a preliminary analysis.Can. J. Gastroenterol.23(Suppl. A) (2009) (Abstract 144).
  • Claudino WM , QuattroneA, BiganzoliL, PestrinM, BertiniI, Di LeoA: Metabolomics: Available results, current research projects in breast cancer, and future applications.J. Clin. Oncol.25(19), 2840–2846 (2007).
  • Goodacre R , VaidyanathanS, DunnWB, HarriganGG, KellDB: Metabolomics by numbers: acquiring and understanding global metabolite data.Trends Biotechnol.22(5), 245–252 (2004).
  • Kaddurah-Daouk R , McEvoyJ, BaillieRAet al.: Metabolomic mapping of atypical antipsychotic effects in schizophrenia.Mol. Psychiatry12(10), 934–945 (2007).
  • Broadhurst DI , BrownM, DunnWBet al.: The application of UPLC/LTQ-Orbitrap mass spectrometry to human metabolite biomarker discovery. A case study: pre-eclampsia.Reprod. Sci.15(2), 208A–208A (2008).
  • Siffedeen JS , RankinKN, FuH, DielemanLA, SlupskyC, FedorakR: Metabolomics in inflammatory bowel disease: differentiating patients with or without IBD.Gastroenterology134(4), A203–A203 (2008).
  • Kind T , TolstikovV, FiehnO, WeissRH: A comprehensive urinary metabolomic approach for identifying kidney cancer.Analytical Biochem.363(2), 185–195 (2007).
  • Kell DB : Metabolomic biomarkers: search, discovery and validation.Expert Rev. Mol. Diagn.7(4), 329–333 (2007).
  • Kaddurah-Daouk R , KristalBS, WeinshilboumRM: Metabolomics: a global biochemical approach to drug response and disease.Ann. Rev. Pharmacol. Toxicol.48, 653–683 (2008).
  • Whiting P , RutjesA, ReitsmaJ, BossuytP, KleijnenJ: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews.BMC Med. Res. Methodol.3, 25 (2003).
  • Ma Y , QinH, LiuWet al.: Ultra-high performance liquid chromatography-mass spectrometry for the metabolomic analysis of urine in colorectal cancer.Dig. Dis. Sci.1–8 (2008).
  • Chan ECY , KohPK, MalMet al.: Metaboloic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).J. Proteome Res.8(1), 352–361 (2009).
  • Piotto M , MoussalliehF, DillmannBet al.: Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy.Metabolomics1–10 (2008).
  • Denkert C , BudcziesJ, WeichertWet al.: Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover.Mol. Cancer7, 72 (2008).
  • Lean CL , NewlandRC, EndeDA, BokeyEL, SmithICP, MountfordCE: Assessment of human colorectal biopsies by 1H MRS: correlation with histopathology.Magn. Reson. Med. Sci.30(5), 525–533 (1993).
  • Qiu Y , CaiG, SuMet al.: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.J. Proteome Res.8(10), 4844–4850 (2009).
  • Qiu Y , CaiG, SuMet al.: Urinary metabonomic study on colorectal cancer.J. Proteome Res.9(3), 1627–1634 (2010).
  • Ritchie SA , AhiahonuPWK, JayasingheDet al.: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.BMC Medicine8, 13 (2010).
  • Monleon D , MoralesJM, BarrasaA, LopezJA, VazquezC, CeldaB: Metabolite profiling of fecal water extracts from human colorectal cancer.NMR Biomed.22, 342–348 (2008).
  • Bezabeh T , SomorjaiR, DolenkoBet al.: Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts.NMR Biomed.22, 593–600 (2009).
  • Dunn WB , EllisDI: Current analytical platforms and methodologies.Trends Anal. Chem.24, 285–294 (2005).
  • Lenz EM , WilsonID: Analytical strategies in metabonomics.J. Proteome Res.6, 443–458 (2007).
  • Robertson DG : Metabolomics in toxicology: a review.Toxicol. Sci.85, 809–822 (2005).
  • Bathen TF , JensenLR, SitterBet al.: MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status.Breast Cancer Res. Treat.104(2), 181–189 (2007).
  • Bullinger D , FrohlichH, KlausFet al.: Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.Analytica Chimica Acta618(1), 29–34 (2008).
  • Frickenschmidt A , FrohlichH, BullingerDet al.: Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients.Biomarkers13(4), 435–449 (2008).
  • Whitehead TL , Kieber-EmmonsT: Applying in vitro NMR spectroscopy and 1H NMR metabonomics to breast cancer characterization and detection.Prog. Nucl. Magn. Reson. Spectrosc.47(3–4), 165–174 (2005).
  • Burns MA , HeW, WuCL, ChengLL: Quantitative pathology in tissue MR spectroscopy based human prostate metabolomics.Technol. Cancer Res. Treat.3(6), 591–598 (2004).
  • Cheng LL , BurnsMA, TaylorJLet al.: Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy.Cancer Res.65(8), 3030–3034 (2005).
  • Sewitch MJ , FournierC, CiampiA, DyachenkoA: Adherence to colorectal cancer screening guidelines in Canada.BMC Gastroenterol.7(1), 39–48 (2007).
  • Rabeneck L , PaszatLF: A population-based estimate of the extent of colorectal cancer screening in Ontario.Am. J. Gastroenterol.99(6), 1141–1144 (2004).
  • McGregor SE , HilsdenRJ, LiFX, BryantHE, MurrayA: Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening.Am. J. Gastroenterol.102(8), 1727–1735 (2007).
  • Casale F , CanaparoR, SerpeLet al.: Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients.Pharmacol. Res.50(2), 173–179 (2004).
  • Chace D : 2005 International conference on metaboloic profiling: November 14–15, NC, USA.Expert Rev. Mol. Diagn.6(2), 135–136 (2006).
  • Seierstad T , RoeK, SitterBet al.: Principle component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy.Molecular Cancer7, 33 (2008).
  • Wang Y , HolmesE, ComelliEMet al.: Topographical variation in metabolic signatures of human gastrointestinal biopsies revealed by high-resolution magic-angle spinning 1H NMR spectroscopy.J. Proteome Res.6(10), 3944–3951 (2007).
  • Hong J , ChenJL: Technology of metabonomics and its application in gastrointestinal cancer.World Chin. J. Dig.16(1), 68–75 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.